AL
CW icon

Aspiriant LLC’s Curtiss-Wright CW Stock Holding History

Aspiriant LLC’s Portfolio CW Stock Details CW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
481
+114
+31% +$83.5K 0.01% 291
2026
Q1 		$250K Buy
+367
New +$244K 0.01% 308

Other funds holding CW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Aspiriant LLC's CW Position: Q2 2026 in Review

Aspiriant LLC increased its Curtiss-Wright (CW) stake by 31% in Q2 2026, buying an estimated $83.5K and bringing the position to 481 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #291.

Aspiriant LLC first reported a position in CW in Q1 2026 and has held it in 2 quarters since. 944 funds tracked by Wall St. Rank hold CW as of Q2 2026.

  • Aspiriant LLC held 481 shares of Curtiss-Wright worth $364K as of Q2 2026.
  • Aspiriant LLC bought 114 Curtiss-Wright shares in Q2 2026, an estimated $83.5K.
  • Curtiss-Wright made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #291 holding.
  • Aspiriant LLC first reported a position in Curtiss-Wright in Q1 2026 and has held it in 2 quarters since.
  • 944 funds tracked by Wall St. Rank held Curtiss-Wright as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.